Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19

Ann Clin Microbiol Antimicrob. 2020 May 30;19(1):23. doi: 10.1186/s12941-020-00368-w.
No abstract available

Keywords: 2019-nCoV; COVID-19; Coronavirus; Ivermectin; SARS-CoV-2; Therapeutics.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections
  • Ivermectin
  • Pandemics
  • Pneumonia, Viral
  • SARS Virus*
  • SARS-CoV-2

Substances

  • Ivermectin